DBI-1, a novel gene related to the Notch family, modulates mitogenic response to insulin-like growth factor 1

被引:11
作者
Hoff, HB [1 ]
Tresini, M [1 ]
Li, S [1 ]
Sell, C [1 ]
机构
[1] Allegheny Univ Hlth Sci, MCP Hahnemann Sch Med, Dept Pathol & Lab Med, Ctr Gerontol Res, Philadelphia, PA 19129 USA
关键词
insulin like growth factor 1; Notch; transformation;
D O I
10.1006/excr.1997.3865
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The insulin-like growth factor 1 (IGF-1) receptor has been found to transform fibroblast cells when overexpressed. The removal of 108 aa from the C-terminus of the IGF-1 receptor abolishes the transforming ability of the receptor without affecting its ability to induce cell growth. The availability of this mutant receptor provides a means to examine the changes in gene expression which take place during transformation, solely in response to an increased number of IGF-1 receptors. Using differential display, we have examined differences in gene expression between cells expressing a wild-type, transforming IGF-1 receptor and cells expressing a C-terminally truncated, nontransforming IGF-1 receptor. We have cloned a novel 6.3-kb cDNA transcript (DBI-1) which is expressed at much lower levels in cells containing the wild-type IGF-1 receptor. The predicted protein sequence of DBI-1 contains seven EGF-like repeats, which bear >90% sequence identity to the rat Notch 2 protein. The cDNA also contains a potential DEAD box in the C-terminal region. The DBI-1 message is detected at relatively high levels in cardiac tissue and at lower levels in lung, liver, and kidney. Antibodies generated to a unique region of the DBI-1 protein recognize a protein of 88 kDa, which is localized in the nucleus. Overexpression of DBI-1 in cells which contain the wild-type IGF-1 receptor diminishes the mitogenic response to IGF-1. (C) 1998 Academic Press.
引用
收藏
页码:359 / 370
页数:12
相关论文
共 45 条
[1]   NOTCH SIGNALING [J].
ARTAVANISTSAKONAS, S ;
MATSUNO, K ;
FORTINI, ME .
SCIENCE, 1995, 268 (5208) :225-232
[2]  
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
[3]  
BASERGA R, 1991, J CELL SCI, V98, P433
[4]  
BASERGA R, 1995, CANCER RES, V55, P249
[5]  
Baserga Renato, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P47
[6]   IDENTIFICATION OF DIFFERENTIALLY EXPRESSED MESSENGER-RNA SPECIES BY AN IMPROVED DISPLAY TECHNIQUE (DDRT-PCR) [J].
BAUER, D ;
MULLER, H ;
REICH, J ;
RIEDEL, H ;
AHRENKIEL, V ;
WARTHOE, P ;
STRAUSS, M .
NUCLEIC ACIDS RESEARCH, 1993, 21 (18) :4272-4280
[7]   Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor [J].
Blakesley, VA ;
Kalebic, T ;
Helman, LJ ;
Stannard, B ;
Faria, TN ;
Roberts, CT ;
LeRoith, D .
ENDOCRINOLOGY, 1996, 137 (02) :410-417
[8]   Intracellular cleavage of notch leads to a heterodimeric receptor on the plasma membrane [J].
Blaumueller, CM ;
Qi, HL ;
Zagouras, P ;
ArtavanisTsakonas, S .
CELL, 1997, 90 (02) :281-291
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]   A FUNCTIONAL INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IS REQUIRED FOR THE MITOGENIC AND TRANSFORMING ACTIVITIES OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
COPPOLA, D ;
FERBER, A ;
MIURA, M ;
SELL, C ;
DAMBROSIO, C ;
RUBIN, R ;
BASERGA, R .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4588-4595